Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JAMA Facial Plastic Surgery|April 8, 2016
Perceptions of Aesthetic Outcome of Linear vs Multiple Z-Plasty Scars in a National SurveyMondhipa Ratnarathorn, Tatyana A Petukhova, April W Armstrong, et al.
JAMA Dermatology|November 6, 2014
Purse-string suture vs second intention healing: results of a randomized, blind clinical trialJayne Joo, Trenton Custis, April W Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer modelAndressa Ardiani, Benedetto Farsaci, Connie J Rogers, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2017
GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against TuberculosisThomas H King, Crystal A Shanley, Zhimin Guo, et al.
Cancer Research|February 13, 2014
Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic processAndressa Ardiani, Sofia R Gameiro, Claudia Palena, et al.
Archives of Dermatological Research|September 21, 2021
Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trialJayne Joo, Aunna Pourang, Catherine N Tchanque-Fossuo, et al.
Journal of the American Academy of Dermatology|August 18, 2014
Set-back versus buried vertical mattress suturing: results of a randomized blinded trialAudrey S Wang, Rebecca Kleinerman, April W Armstrong, et al.
Vaccine|November 14, 2006
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsAurelia A Haller, Georg M Lauer, Thomas H King, et al.
Vaccines|September 23, 2022
Bridging Animal and Human Data in Pursuit of Vaccine LicensureCourtney L Finch, William E Dowling, Thomas H King, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
Pageof 3